BIOMAT Database Logo BIOMAT Database Logo

Prevalence of anti-HTLV-I antibodies in HIV-seropositive individuals in Guadalajara, Mexico. 1993

E Vazquez-Valls, and P I Campos-Lopez, and B M Torres-Mendoza, and I Alvarez-Maya, and A Gonzalez-Mendoza

UI MeSH Term Description Entries
D008297 Male Males
D008800 Mexico A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015481 HTLV-I Antibodies Antibodies reactive with the HTLV-I ANTIGENS. ATLV Antibodies,Human T-Cell Leukemia Virus I Antibodies,Leukemia-Lymphoma Virus I Antibodies, Human T-Cell,T-Cell Leukemia Virus I Antibodies, Adult,T-Cell Leukemia Virus I Antibodies, Human,HTLV I Antibodies,Human T Cell Leukemia Virus I Antibodies,Leukemia Lymphoma Virus I Antibodies, Human T Cell,T Cell Leukemia Virus I Antibodies, Adult,T Cell Leukemia Virus I Antibodies, Human,Antibodies, ATLV,Antibodies, HTLV I,Antibodies, HTLV-I,I Antibodies, HTLV
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

E Vazquez-Valls, and P I Campos-Lopez, and B M Torres-Mendoza, and I Alvarez-Maya, and A Gonzalez-Mendoza
[Anti HTLV-I antibody titers in seropositive infected individuals].
September 1994, Revista medica de Chile,
E Vazquez-Valls, and P I Campos-Lopez, and B M Torres-Mendoza, and I Alvarez-Maya, and A Gonzalez-Mendoza
Prevalence of HTLV-I/II antibodies in HIV seropositive and HIV seronegative STD patients in Vellore region in southern India.
January 1995, Scandinavian journal of infectious diseases,
E Vazquez-Valls, and P I Campos-Lopez, and B M Torres-Mendoza, and I Alvarez-Maya, and A Gonzalez-Mendoza
Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
January 1987, AIDS research and human retroviruses,
E Vazquez-Valls, and P I Campos-Lopez, and B M Torres-Mendoza, and I Alvarez-Maya, and A Gonzalez-Mendoza
Detection of anti-HTLV-I Tax antibodies in HTLV-I enzyme-linked immunosorbent assay-negative individuals.
August 1989, Blood,
E Vazquez-Valls, and P I Campos-Lopez, and B M Torres-Mendoza, and I Alvarez-Maya, and A Gonzalez-Mendoza
HTLV-I in HIV seropositive Indian blood donors.
December 1996, The Journal of communicable diseases,
E Vazquez-Valls, and P I Campos-Lopez, and B M Torres-Mendoza, and I Alvarez-Maya, and A Gonzalez-Mendoza
Antibodies to HCV and HTLV-I in a group of HIV-seropositive STD patients.
August 1995, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
E Vazquez-Valls, and P I Campos-Lopez, and B M Torres-Mendoza, and I Alvarez-Maya, and A Gonzalez-Mendoza
Antibodies to HTLV-1 in saliva of seropositive individuals from Japan.
January 1987, Viral immunology,
E Vazquez-Valls, and P I Campos-Lopez, and B M Torres-Mendoza, and I Alvarez-Maya, and A Gonzalez-Mendoza
[Prevalence of anti-HTLV-I antibodies in intravenous drug addicts in Argentina].
January 1989, Medicina,
E Vazquez-Valls, and P I Campos-Lopez, and B M Torres-Mendoza, and I Alvarez-Maya, and A Gonzalez-Mendoza
[Prevalence and prognostic significance of anti-HTLV-I and anti-HIV-2 antibodies in patients with HIV infection in the Roman region].
January 1988, Bollettino dell'Istituto sieroterapico milanese,
E Vazquez-Valls, and P I Campos-Lopez, and B M Torres-Mendoza, and I Alvarez-Maya, and A Gonzalez-Mendoza
[Anti-LAV/HTLV III antibodies in wives of seropositive hemophilic patients].
October 1986, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!